Clinical Trials Directory

Trials / Unknown

UnknownNCT03524300

Clinical Efficacy Between Robotic and Laparoscopic Total Gastrectomy in Patients With Clinical Stage I Gastric Cancer

Prospective Randomized Controlled Trial for Comparison of Clinical Efficacy Between Robotic and Laparoscopic Total Gastrectomy in Patients With Clinical Stage I Gastric Cancer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Fujian Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to explore the clinical efficacy between robotic and laparoscopic total gastrectomy in patients with clinical Stage I gastric cancer

Detailed description

Robotic surgery has been developed with the aim of improving surgical quality and overcoming the limitations of conventional laparoscopy in the performance of complex mini-invasive procedures. The study is designed to explore the clinical outcomes of the robotic assisted total gastrectomy by comparing short- and long-term outcomes including financial cost of robotic and laparoscopic assisted total gastrectomy in the treatment of clinical Stage I gastric adenocarcinoma (cStage IA(T1N0M0)or cStage IB(T1N1M0,T2N0M0)).

Conditions

Interventions

TypeNameDescription
PROCEDURERobotic Assisted Total GastrectomyAfter exclusion of T4b, bulky lymph nodes, or distant metastasis case,robotic assisted total gastrectomy will be performed in the experimental group.
PROCEDURELaparoscopic Assisted Total GastrectomyAfter exclusion of T4b, bulky lymph nodes, or distant metastasis case,laparoscopic assisted total gastrectomy will be performed in the experimental group.

Timeline

Start date
2018-06-01
Primary completion
2021-11-30
Completion
2024-11-30
First posted
2018-05-14
Last updated
2020-02-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03524300. Inclusion in this directory is not an endorsement.